Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation? (Q30318368)

17 June 2017

title

Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation? (English)

1 reference

17 June 2017

1 reference

5

Henning Dralle

1 reference

17 June 2017

Andreas Machens

1

1 reference

17 June 2017

Alf Spitschak

series ordinal

2

1 reference

17 June 2017

Kerstin Lorenz

series ordinal

3

1 reference

17 June 2017

Brigitte M Pützer

series ordinal

4

1 reference

17 June 2017

publication date

1 December 2011

1 reference

17 June 2017

published in

Clinical Endocrinology

1 reference

17 June 2017

volume

75

1 reference

17 June 2017

issue

6

1 reference

17 June 2017

page(s)

801-805

1 reference

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

17 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Early Malignant Progression of Hereditary Medullary Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Medullary thyroid cancer: management guidelines of the American Thyroid Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

E2F1 in melanoma progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Reference intervals for serum calcitonin in men, women, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04158.X

10.1111/J.1365-2265.2011.04158.X

21 January 2018

Identifiers

DOI

1 reference

17 June 2017

1 reference